Tuesday, November 10, 2015
- 9:00AM-11:00AM
-
Abstract Number: 2987
An EULAR Study Group Pilot Study on Reliability of Simple� Capillaroscopic Definitions to Describe Capillary Morphology in Rheumatic Diseases
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster III- 9:00AM-11:00AM
-
Abstract Number: 2701
An Expansion of Rare Lineage Intestinal Microbes Characterize Rheumatoid Arthritis
Rheumatoid Arthritis - Human Etiology and Pathogenesis Poster III- 9:00AM-11:00AM
-
Abstract Number: 2707
An in Vitro Bovine Bone Chip Model with Micro-CT: A Model for the Assessment of Autoantibody Mediated Bone Resorption
Rheumatoid Arthritis - Human Etiology and Pathogenesis Poster III- 9:00AM-11:00AM
-
Abstract Number: 2423
An Open-Label Extension Study to Assess the Long-Term Safety and Clinical Benefit of Etanercept on Children and Adolescents with Extended Oligoarticular Juvenile Idiopathic Arthritis, Enthesitis-Related Arthritis, or Psoriatic Arthritis: A 4-Year Update
Pediatric Rheumatology - Clinical and Therapeutic Aspects Posters (ACR): Imaging and Novel Clinical Interventions- 9:00AM-11:00AM
-
Abstract Number: 2382
An Outsourced Health-Enhancing Physical Activity Program for People with Rheumatoid Arthritis. Exploration of the Maintenance Phase
Orthopedics, Low Back Pain and Rehabilitation Poster (ARHP): Rehabilitation Sciences- 9:00AM-11:00AM
-
Abstract Number: 2827
Analysis of HLA-B27 Transgenic Rats Reveals Specific Gut Transcriptome and Microbiome Signatures Associated with Inflammation
Spondylarthropathies and Psoriatic Arthritis - Pathogenesis, Etiology Poster II- 9:00AM-11:00AM
-
Abstract Number: 2656
Analysis of Morning Stiffness Response in Rheumatoid Arthritis Patients with Low Disease Activity Receiving Delayed-Release Prednisone Plus Dmards As Compared to Placebo Plus Dmards
Rheumatoid Arthritis - Clinical Aspects Poster Session III- 9:00AM-11:00AM
-
Abstract Number: 2916
Analysis of Risk Factors of the Progression to Chronic Kidney Disease and Comorbidities in Lupus Nephritis
Systemic Lupus Erythematosus - Clinical Aspects and Treatment Poster Session III- 9:00AM-11:00AM
-
Abstract Number: 2377
Anti 3-Hydroxy-3-Methylglutaryl-Coenzyme a Reductase in Systremic Sclerosis
Muscle Biology, Myositis and Myopathies Poster II: Autoantibodies and Treatments in Inflammatory Myopathies- 9:00AM-11:00AM
-
Abstract Number: 2433
Anti Interferon-Gamma (IFNg) Monoclonal Antibody Treatment in a Child with NLRC4-Related Disease and Severe Hemophagocytic Lymphohistiocytosis (HLH)
Pediatric Rheumatology - Clinical and Therapeutic Aspects Posters (ACR): Imaging and Novel Clinical Interventions- 9:00AM-11:00AM
-
Abstract Number: 2456
Anti SRP+Ve Myositis in Childhood. Presentation and Physiotherapy Treatment of This Rare Childhood Myositis
Pediatric Rheumatology - Clinical and Therapeutic Aspects Posters (ARHP): Pediatrics- 9:00AM-11:00AM
-
Abstract Number: 2364
Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme a Reductase Positive Myopathy Patients without Statin Exposure May Have a Progressive Disease That Worsens Despite Aggressive Immunosuppressive Therapy
Muscle Biology, Myositis and Myopathies Poster II: Autoantibodies and Treatments in Inflammatory Myopathies- 9:00AM-11:00AM
-
Abstract Number: 3045
Anti-Alpha-Enolase Antibodies in Behçet’s Disease: A Marker of Articular Disease Activity?
Vasculitis Poster III- 9:00AM-11:00AM
-
Abstract Number: 2590
Anti-Citrullinated Protein Antibody and Radiographic Disease Progression in Rheumatoid Arthritis